Overview

Safety and Efficacy of Hydrochlorothiazide in the Treatment of Hypernatremia in Critically Ill Patients

Status:
Unknown status
Trial end date:
2020-03-10
Target enrollment:
Participant gender:
Summary
HYDRA is a randomized clinical trial designed to evaluate safety and efficiency of hydrochlorothiazide in critical patients with hypernatremia
Phase:
Phase 2
Details
Lead Sponsor:
University of Sao Paulo
Treatments:
Hydrochlorothiazide